🇺🇸 FDA
Company

Quince

Quince Therapeutics

QNCX biotech USA

Quick answer

Quince is a biotech company (QNCX) headquartered in SOUTH SAN FRANCISCO, CA, USA with 8 tracked pipeline programs.

Pipeline (8)

project

Dexamethasone

Crohn's Disease

Phase 3 · small_molecule · terminated

1 trials project

Dexamethasone sodium phosphate

Ataxia Telangiectasia

Phase 3 · small_molecule · completed

2 trials project

EryDex Low dose DSP

Nervous System Disease

Phase 3 · small_molecule · completed

1 trials project

EryDex System

Ataxia Telangiectasia

Phase 3 · other · terminated

1 trials project

Dex 21-P

Ulcerative Colitis

Phase 2 · small_molecule · completed

1 trials project

Dexamethasone

Nervous System Disorder

Phase 2 · small_molecule · completed

1 trials project

DSP loaded RBC using EryDex System

Healthy

Phase 1 · small_molecule · completed

1 trials project

EryDex (dexamethasone sodium phosphate encapsulated erythrocytes)

Healthy

Phase 1 · small_molecule · completed

1 trials

Patents (1)

patent

US 12311059

Process for the preparation of erythrocytes loaded with one or more substances o

Expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)